Paxlovid Boceprevir Yepakati CAS 565456-77-1 Assay ≥99.0%
Commercial Supply PF-07321332 Paxlovid Inoenderana Nepakati Nemhando yepamusoro
L-tert-Leucine (H-Tle-OH) CAS 20859-02-3
Caronic Anhydride CAS 67911-21-1
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride 565456-77-1
Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS 328086-60-8
6,6-Dimethyl-3-azabicyclo[3.1.0]hexane CAS 943516-54-9
Chemical Name | (1R,2S,5S) -6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride |
Mashoko anoreva zvakafanana | Methyl (1R,2S,5S) -6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate Hydrochloride |
Nhamba yeCAS | 565456-77-1 |
Nhamba yeCAT | RF-PI318 |
Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Matani |
Molecular Formula | C9H15NO2.ClH |
Molecular Weight | 205.683 |
Brand | Ruifu Chemical |
Item | Zvinotsanangurwa |
Chitarisiko | Ichena kusvika kuOff-White Powder |
Identification A | IR: Yakafanana neReference Substance |
Kuzivikanwa B | Nguva Yekuchengeta: Yakafanana neReference Substance |
Enantiomer | ≤0.15% |
Kusachena kwakabatana (neHPLC) | |
Kusachena Kusingazivikanwi | ≤0.20% |
Zvose Zvisina Kuchena | ≤1.0% |
Mvura | ≤0.50% |
Residue paIgnition | ≤0.10% |
Heavy Metals | ≤20ppm |
Assay | ≥99.0% |
Test Standard | Enterprise Standard |
Usage | Pakati pePF-07321332 Paxlovid (CAS 2628280-40-8) uye Boceprevir (CAS 394730-60-0) |
Package: Bhodhoro, Aluminium foil bag, Cardboard dhiramu, 25kg/Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza, mwando uye tumbuyu.
(1R,2S,5S) -6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride (CAS 565456-77-1) inonzi azabicyclohexane derivative inoshandiswa mukugadzirira hepatitis C. utachiona (HCV) NS3 serine protease inhibitor.Ndiyo yepakati yePF-07321332 Paxlovid (CAS 2628280-40-8) uye Boceprevir (CAS 394730-60-0).PF-07321332 ine simba uye inoshanda nemuromo SARS-CoV 3C-yakafanana neprotease (3CLPRO) inhibitor .PF-07321332 yakanangana nehutachiona hweSARS-CoV-2 uye inogona kushandiswa kutsvagurudza COVID-19.Boceprevir (INN, trade name Victrelis) iprotease inhibitor inoshandiswa sekurapa hepatitis C genotype 1. Inosunga kuHCV nonstructural 3 NS3 (HCV) inoshanda nzvimbo.Yakanga ichigadzirwa neSchering-Plough, asi ikozvino iri kugadzirwa neMerck kubvira pakawanikwa Schering muna 2009. Yakatenderwa neFDA musi waChivabvu 13, 2011.